As part of the project workplan, the BD4QoL Consortium is reflecting on the best mechanisms to disseminate and exploit the new knowledge that the project is producing, in order to increase the impact of its results for the benefit not only of Consortium’s partners but also of the European society as a whole.

MME contributed to this effort by formulating two specific elements of the BD4QoL Market Study: the outline of the value proposition and the identification of the addressable market segments.

The value proposition for BD4QoL has been articulated around 7 different bundles of the basic project components (i.e., mobile apps, PoC application, chatbot, models, etc.) that represent self-contained solutions for targeting specific needs in cancer survivorship management, such as data collection and visualization, patient motivation and self-management, follow-up monitoring and alerting, prediction of QoL decay, etc.

The above bundles have then been compared to the unmet needs in the current market landscape, and relevant market segments most likely to benefit from the BD4QoL proposal have been identified, including patients and caregivers, healthcare providers and payers, healthcare authorities, pharma companies, patients’ and medical associations, service providers.

The depth and breadth of this work will allow to proceed to the next step that, jointly with the competition analysis conducted by other partners, would allow to develop an effective business plan, for ensuring the full exploitation of project results.